Package 60505-3947-3

Brand: adefovir dipivoxil

Generic: adefovir dipivoxil
NDC Package

Package Facts

Identity

Package NDC 60505-3947-3
Digits Only 6050539473
Product NDC 60505-3947
Description

1 BOTTLE in 1 CARTON (60505-3947-3) / 30 TABLET in 1 BOTTLE

Marketing

Marketing Status
Discontinued 2026-11-30
Brand adefovir dipivoxil
Generic adefovir dipivoxil
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "bd0233d0-e141-a321-66a5-4afd09dbabfe", "openfda": {"upc": ["0360505394739"], "unii": ["U6Q8Z01514"], "rxcui": ["881341"], "spl_set_id": ["08e07fae-3191-b6a3-c894-d3a8cc53923f"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (60505-3947-3)  / 30 TABLET in 1 BOTTLE", "package_ndc": "60505-3947-3", "marketing_end_date": "20261130", "marketing_start_date": "20180925"}], "brand_name": "Adefovir dipivoxil", "product_id": "60505-3947_bd0233d0-e141-a321-66a5-4afd09dbabfe", "dosage_form": "TABLET", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Analog [EXT]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "60505-3947", "generic_name": "adefovir dipivoxil", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Adefovir dipivoxil", "active_ingredients": [{"name": "ADEFOVIR DIPIVOXIL", "strength": "10 mg/1"}], "application_number": "ANDA205459", "marketing_category": "ANDA", "marketing_end_date": "20261130", "marketing_start_date": "20180925"}